Company: SXTPW
Filing Date: 2025-03-27
Form Type: S-1/A
Source: 0001013762-25-003353
Chunk: 231

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: S-1/A
Chunk 231
---
 underwriting discount and commission and other estimated IPO expenses. As a result of the completion of the IPO and as required under the terms of the respective agreements, on July 14, 2023: |

| o | The Company issued an aggregate of 28,460 shares of common stock upon conversion of the Company’s outstanding debt obligations as follows: (i) 6,404 shares issued to the holders of the 2022 and 2023 Bridge Notes and the Related Party Notes, (ii) 3,583 shares issued pursuant to the Xu Yu Note, including the Amendment, and (iii) 18,473 shares issued to Knight upon conversion of the principal amount of the Convertible Knight Loan, in each case at the conversion prices detailed in Note 8. |

| o | The Company issued 488 shares of common stock to BioIntelect as deferred equity compensation valued in the amount of $155,000. |

In July 2023, the Company issued an aggregate of 3,075shares of common stock upon the exercise of (i) 525Bridge Warrants (as defined below), (ii) 1,000Non-tradeable Warrants, and (iii) 1,550Tradeable Warrants.

On July 25, 2023, the Company converted 2,162shares of Series A Preferred Stock held by Knight into 760shares of common stock.

F-20 On December 28, 2023, the Company issued 176shares of common stock to Red Chip as deferred equity compensation valued in the amount of $ 40,000based on the 30-day average price of the publicly traded common shares after the IPO, as required by the terms of the investment relations consulting agreement signed in March 2023. On January 29, 2024, the Company, entered into an Underwriting Agreement with WallachBeth Capital LLC, relating to the Company’s public offering (the “January 2024 Offering”) of 87,682units at an offering price of $ 23.10per unit and 16,652pre-funded units at an offering price of $ 22.50per pre-funded unit. Each unit consisted of oneshare of common stock and onewarrant exercisable for oneshare of common stock (the “January 2024 Warrants”). Each pre-funded unit consists of onepre-funded warrant exercisable for oneshare of common stock (the “January 2024 Pre-Funded Warrants”) and onewarrant identical